Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight

The pandemic of SARS-CoV-2 has necessitated expedited research efforts towards finding potential antiviral targets and drug development measures. While new drug discovery is time consuming, drug repurposing has been a promising area for elaborate virtual screening and identification of existing FDA...

Descripción completa

Detalles Bibliográficos
Autores principales: Begum, Feroza, Srivastava, Amit Kumar, Ray, Upasana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282484/
https://www.ncbi.nlm.nih.gov/pubmed/34303192
http://dx.doi.org/10.1016/j.bbrc.2021.07.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282484/
https://www.ncbi.nlm.nih.gov/pubmed/34303192
http://dx.doi.org/10.1016/j.bbrc.2021.07.050

Ejemplares similares